Is it time to reconsider initial antibiotic treatment strategies for severe urinary tract infections in Europe? - Archive ouverte HAL Access content directly
Journal Articles Clinical Microbiology and Infection Year : 2007

Is it time to reconsider initial antibiotic treatment strategies for severe urinary tract infections in Europe?

(1) , (1) , (1) , (1) , (1) , (1)
1

Abstract

Until recently, most reported cases of bacteraemia caused by multidrug-resistant strains of Enterobacteriacae producing an extended-spectrum b-lactamase (ESBL) in Europe have been nosocomial in origin. However, increasing numbers of reports of community-acquired bacteraemia and urinary tract infection caused by ESBL-producing microorganisms suggest that the geographical origin of patients should be taken into account as a risk-factor for possible ESBL production. Early identification of patients at highrisk of infection with ESBL-producing microorganisms, based on their geographical origin and travel history, should help to optimise initial antibiotic treatment strategies for severe urinary tract infections in Europe.

Dates and versions

pasteur-03204201 , version 1 (21-04-2021)

Identifiers

Cite

J.R. Zahar, M. Lecuit, E. Carbonnelle, F. Ribadeau-Dumas, X. Nassif, et al.. Is it time to reconsider initial antibiotic treatment strategies for severe urinary tract infections in Europe?. Clinical Microbiology and Infection, 2007, 13 (3), pp.219-221. ⟨10.1111/j.1469-0691.2007.01666.x⟩. ⟨pasteur-03204201⟩

Collections

PASTEUR
4 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More